High Grade Neuroendocrine Cancers
1 clinical trials · Condition
◉ Watch High Grade Neuroendocrine Cancers
| Record | Firm | Date |
|---|---|---|
| Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers (NCT04802174) | National Cancer Institute (NCI) | 2021-06-01 |
Track High Grade Neuroendocrine Cancers automatically
Every clearance here is in the API, with alerts when new ones post.